Loading...

ECS Botanics Holdings Ltd

ECS.AXASX
Healthcare
Drug Manufacturers - Specialty & Generic
A$0.008
A$0.00(0.00%)

ECS Botanics Holdings Ltd (ECS.AX) Stock Overview

Explore ECS Botanics Holdings Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.6/100

Key Financials

Market Cap10.4M
P/E Ratio-7.85
EPS (TTM)N/A
ROE-0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$0.01
1 Month$0.01
3 Months$0.01
1 Year Target$0.01

ECS.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ECS Botanics Holdings Ltd (ECS.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.41, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.85 and a market capitalization of 10.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;